Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.8%

2 terminated/withdrawn out of 52 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

N/A
25(65.8%)
Phase 2
5(13.2%)
Phase 3
4(10.5%)
Phase 4
3(7.9%)
Phase 1
1(2.6%)
38Total
N/A(25)
Phase 2(5)
Phase 3(4)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials
NCT05287321Phase 3Recruiting

The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia

Role: collaborator

NCT06141798Not ApplicableRecruiting

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Role: collaborator

NCT03306901Not ApplicableActive Not Recruiting

Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT05505357Not ApplicableRecruiting

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)

Role: collaborator

NCT05766644Not ApplicableUnknown

App-based Education Program for CKD

Role: collaborator

NCT00931970Unknown

Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)

Role: collaborator

NCT02909426Unknown

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Role: collaborator

NCT04835883Phase 2Unknown

Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Role: collaborator

NCT02114359Phase 3Completed

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

Role: collaborator

NCT03046745Unknown

Gastric Cancer Registry for Epidemiology and Molecular Risk Factor

Role: collaborator

NCT03665402Not ApplicableCompleted

A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status

Role: collaborator

NCT03929887Recruiting

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Role: collaborator

NCT01991145Not ApplicableCompleted

Allogeneic UCB Therapy With EPO in Children With CP

Role: collaborator

NCT03213470Not ApplicableCompleted

Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI

Role: collaborator

NCT01943175Completed

Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia

Role: collaborator

NCT03088657Unknown

Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study

Role: collaborator

NCT01925014Not ApplicableCompleted

Low vs. Standard Dose CT for Appendicitis Trial

Role: collaborator

NCT01112280Not ApplicableCompleted

Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network

Role: collaborator

NCT03005756Not ApplicableUnknown

Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients

Role: collaborator

NCT03183856Not ApplicableCompleted

Comparison of Ambulatory and Functional Improvement by Morning Walk

Role: collaborator